(Q51915037)

English

Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

0 references

author name string

Maartje A M Berends

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Josje Snoek

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Elke M G J de Jong

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

J Han Van Krieken

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Robert J de Knegt

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Martijn G H van Oijen

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Peter C M van de Kerkhof

7

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Joost P H Drenth

8

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

27

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

639-645

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Review article: the evolving role of liver biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

A novel panel of blood markers to assess the degree of liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01489.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2007.01489.X

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17498249

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51915037&oldid=943169482"